Haemonetics
242 hedge funds and large institutions have $3.26B invested in Haemonetics in 2022 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 97 increasing their positions, 83 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.9% more ownership
Funds ownership: 97.99% → 100.9% (+2.9%)
6% less funds holding
Funds holding: 257 → 242 (-15)
33% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 42
Holders
242
Holding in Top 10
2
Calls
$3.56M
Puts
$1.81M
Top Buyers
| 1 | +$215M | |
| 2 | +$69M | |
| 3 | +$20.2M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$16.9M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$14M |
Top Sellers
| 1 | -$46.8M | |
| 2 | -$46.5M | |
| 3 | -$46.3M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$27.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$18.8M |